Skip to main content
SpringerLink
Log in

Systemic Manifestations of Sarcoidosis

  • Reference work entry
  • First Online:
Albert and Jakobiec's Principles and Practice of Ophthalmology

Abstract

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology with a heterogeneous clinical presentation, which seems to result from an interplay between environmental factors in genetically predisposed individuals. The main hallmark of sarcoidosis is the development of noncaseating granulomas in the lungs, lymph nodes, and skin typically; however, unpredictable affection of any organ system is possible, which makes diagnosis often difficult for health providers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 5,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 6,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Statement on Sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55.

    Google Scholar 

  2. Thomas KW, Hunninghake GW. Sarcoidosis. J Am Med Assoc. 2003;289:3300–3.

    Article  Google Scholar 

  3. James DG. Descriptive definition and historic aspects of sarcoidosis. Clin Chest Med. 1997;18:663–79.

    Article  CAS  PubMed  Google Scholar 

  4. Grassi C, Rizzato G, Pozzi E, editors. Sarcoidosis and other granulomatous disorders: proceedings of the 11th world congress. New York: Excerpta Medica; 1988.

    Google Scholar 

  5. Sharma OP, editor. Sarcoidosis: clinical management. London: Butterworth; 1984.

    Google Scholar 

  6. Sharma OP. Sarcoidosis. Dis Mon. 1990;36:469.

    Article  CAS  PubMed  Google Scholar 

  7. Case records of the Massachusetts General Hospital: case 6–1990. N Engl J Med. 1990;322:388.

    Google Scholar 

  8. Usui Y, Kaiser ED, See RF, et al. Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:167–75.

    PubMed  Google Scholar 

  9. Thorne JE, Brucker AJ. Choroidal white lesions as an early manifestation of sarcoidosis. Retina. 2000;20:8–15.

    Article  CAS  PubMed  Google Scholar 

  10. Dithmar S, Waring GO III, Goldblum TA, Grossniklaus HE. Conjunctival deposits as an initial manifestation of sarcoidosis. Am J Ophthalmol. 1999;128:361–2.

    Article  CAS  PubMed  Google Scholar 

  11. Sivakumar M, Chee SP. A case series of ocular disease as the primary manifestation in sarcoidosis. Ann Acad Med Singap. 1998;27:560–6.

    CAS  PubMed  Google Scholar 

  12. Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis. 2018;9(11):227–40.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016;48(6):1690–9.

    Article  PubMed  Google Scholar 

  14. Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers. 2019;5(1):45.

    Article  PubMed  Google Scholar 

  15. Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, et al. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016;13(8):1244–52.

    Article  PubMed  Google Scholar 

  16. Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L. Sarcoidosis in black women in the United States: data from the Black Women’s Health Study. Chest. 2011;139(1):144–50.

    Article  PubMed  Google Scholar 

  17. Dumas O, Abramovitz L, Wiley AS, Cozier YC, Camargo CA. Epidemiology of sarcoidosis in a prospective cohort study of U.S. women. Ann Am Thorac Soc. 2016;13(1):67–71.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Morimoto T, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31:372–9.

    Article  CAS  PubMed  Google Scholar 

  19. Yoon HY, Kim HM, Kim YJ, Song JW. Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir Res. 2018;19(1):158.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sweiss NJ, Korsten P, Baughman RP. Sarcoidosis. In: Kelley & Firestein’s textbook of rheumatology. 10th ed. Philadelphia: Elsevier; 2017. p. 1983–96.

    Chapter  Google Scholar 

  21. Hoffman AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Pediatr. 2004;93:30–6.

    Article  Google Scholar 

  22. Roy M, Sharma OP, Chan K. Sarcoidosis presenting in infancy: a rare occurrence. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:224–7.

    CAS  PubMed  Google Scholar 

  23. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61(11):980–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Park JE, Kim YS, Kang MJ, Kim CJ, Han CH, Lee SM, et al. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003–2015: a nationwide population-based study. Respir Med. 2018;144S:S28–34.

    Article  PubMed  Google Scholar 

  25. Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J. 2018;51(2):1701815.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tukey MH, Berman JS, Boggs DA, White LF, Rosenberg L, Cozier YC. Mortality among African American women with sarcoidosis: data from the Black Women’s Health Study. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(2):128–33.

    CAS  PubMed  Google Scholar 

  27. Ungprasert P, Carmona EM, Utz JP, Ryu JH, Crowson CS, Matteson EL. Epidemiology of sarcoidosis 1946–2013: a population-based study. Mayo Clin Proc. 2016;91(2):183–8.

    Article  PubMed  Google Scholar 

  28. Nardi A, Brillet PY, Letoumelin P, Girard F, Brauner M, Uzunhan Y, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J. 2011;38(6):1368–73.

    Article  CAS  PubMed  Google Scholar 

  29. Ogundipe F, Mehari A, Gillum R. Disparities in sarcoidosis mortality by region, urbanization, and race in the United States: a multiple cause of death analysis. Am J Med. 2019;132(9):1062–8.

    Article  PubMed  Google Scholar 

  30. Gerke AK. Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med. 2014;20(5):472–8.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Cozier YC, Coogan PF, Govender P, Berman JS, Palmer JR, Rosenberg L. Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women’s Health Study. Chest. 2015;147(4):1086–93.

    Article  PubMed  Google Scholar 

  32. Dumas O, Boggs KM, Cozier YC, Stampfer MJ, Camargo CA. Prospective study of body mass index and risk of sarcoidosis in US women. Eur Respir J. 2017;50(4):1701397.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324–30.

    Article  PubMed  Google Scholar 

  34. Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, Höglund CO, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med. 2010;181(11):1217–22.

    Article  PubMed  Google Scholar 

  35. Esteves T, Aparicio G, Garcia-Patos V. Is there any association between sarcoidosis and infectious agents?: a systematic review and meta-analysis. BMC Pulm Med. 2016;16(1):165.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J. 2007;30(3):508–16.

    Article  CAS  PubMed  Google Scholar 

  37. Chen ES, Moller DR. Etiologies of sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):6–18.

    Article  CAS  PubMed  Google Scholar 

  38. Becker A, Vella G, Galata V, Rentz K, Beisswenger C, Herr C, et al. The composition of the pulmonary microbiota in sarcoidosis – an observational study. Respir Res. 2019;20(1):46.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Webber MP, Yip J, Zeig-Owens R, Moir W, Ungprasert P, Crowson CS, et al. Post-9/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers. Respir Med. 2017;132:232–7.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Schurmann M. Genetics of sarcoidosis. Semin Respir Crit Care Med. 2003;24:213–22.

    Article  PubMed  Google Scholar 

  41. Schurmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med. 2000;162(3 Pt 1):861–4.

    Article  CAS  PubMed  Google Scholar 

  42. Rutherford RM, Brutsche MH, Kearns M, et al. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:191–8.

    PubMed  Google Scholar 

  43. Grunewald J, Eklund A. Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179(4):307–12.

    Article  PubMed  Google Scholar 

  44. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med. 1990;115:36–42.

    CAS  PubMed  Google Scholar 

  45. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156:4952–60.

    CAS  PubMed  Google Scholar 

  46. Crystal RG, Bitterman PB, Rennard SI, et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med. 1984;310:235–44.

    Article  CAS  PubMed  Google Scholar 

  47. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987;135:747.

    CAS  PubMed  Google Scholar 

  48. Williams WJ, Erasmus DA, James EMV, et al. The fine structure of sarcoid and tuberculous granulomas. Postgrad Med J. 1970;46:496.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kirkpatrick CJ, Curry A, Bisset DL. Light- and electron-microscopic studies on multinucleated giant cells in sarcoid granuloma: new aspects of asteroid and Schaumann bodies. Ultrastruct Pathol. 1988;12:581–97.

    Article  CAS  PubMed  Google Scholar 

  50. Kitaichi M. Pathology of pulmonary sarcoidosis. Clin Dermatol. 1986;4:108–15.

    Article  CAS  PubMed  Google Scholar 

  51. Cain H, Kraus B. Immunofluorescence microscopic demonstration of vimentin filaments in asteroid bodies of sarcoidosis. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;42:213.

    Article  CAS  PubMed  Google Scholar 

  52. Bennett D, Bargagli E, Refini RM, Rottoli P. New concepts in the pathogenesis of sarcoidosis (accepted manuscript). Expert Rev Respir Med. 2019;13(10):981–91.

    Article  CAS  PubMed  Google Scholar 

  53. Kveim A. A new and specific cutaneous reaction in Boeck’s sarcoid. Nord Med. 1941;9:169.

    Google Scholar 

  54. Kinloch AJ, Kaiser Y, Wolfgeher D, Ai J, Eklund A, Clark MR, et al. In situ humoral immunity to vimentin in HLA-DRB1*03+ patients with pulmonary sarcoidosis. Front Immunol. 2018;9:1516.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC, et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med. 2010;181(4):360–73.

    Article  CAS  PubMed  Google Scholar 

  56. Dubaniewicz A. Microbial and human heat shock proteins as “danger signals” in sarcoidosis. Hum Immunol. 2013;74(12):1550–8.

    Article  CAS  PubMed  Google Scholar 

  57. Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA, et al. Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol. 2013;173(3):512–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Hinderer S, Brachmann R, Nedder KH, Bucher J, Beischer W. Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease. Vasa. 1991;20(2):100–8.

    CAS  PubMed  Google Scholar 

  59. Prasse A, Katic C, Germann M, et al. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med. 2008;177:330–6.

    Article  CAS  PubMed  Google Scholar 

  60. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155–67.

    Article  PubMed  Google Scholar 

  61. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003;289(24):3300–3.

    Article  PubMed  Google Scholar 

  62. Chen ES, Moller DR. Sarcoidosis – scientific progress and clinical challenges. Nat Rev Rheumatol. 2011;7(8):457–67.

    Article  CAS  PubMed  Google Scholar 

  63. Karakaya B, Kaiser Y, van Moorsel CHM, Grunewald J. Lofgren’s syndrome: diagnosis, management, and disease pathogenesis. Semin Respir Crit Care Med. 2017;38(4):463–76.

    Article  PubMed  Google Scholar 

  64. Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J. 1998;12(5):1197–9.

    Article  CAS  PubMed  Google Scholar 

  65. Mana J, Gomez-Vaquero C, Montero A, et al. Lofgren’s syndrome revisited: a study of 186 patients. Am J Med. 1999;107(3):240–5.

    Article  CAS  PubMed  Google Scholar 

  66. Heerfordt CF. Über eine “Febris uveo-parotidea subchronica” an der Glandula parotis und der Uvea des Auges lokalisiert und häufug mit Paresen cerebrospinaler Nerven kompliziert. Albrecht von Graefes Arch Ophthalmol. 1909;70(2):254–73.

    Article  Google Scholar 

  67. Blair MP, Rizen M. Heerfordt syndrome with internal ophthalmoplegia. Arch Ophthalmol. 2005;123(7):1017.

    Article  PubMed  Google Scholar 

  68. Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol. 1986;30(4):215–28.

    Article  CAS  PubMed  Google Scholar 

  69. Jamilloux D, Maucort-Boulch S, Kerever S, et al. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis. Eur Respir J. 2016;48(6):1700–9.

    Article  PubMed  Google Scholar 

  70. Wells AU. Sarcoidosis: a benign disease or a culture of neglect? Respir Med. 2018;144S:S1–2.

    Google Scholar 

  71. Huang CT, Heurich AE, Sutton AL, Lyons HA. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis. 1981;62(4):231–8.

    CAS  PubMed  Google Scholar 

  72. Arcasoy SM, Christie JD, Pochettino A, et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest. 2001;120(3):873–80.

    Article  CAS  PubMed  Google Scholar 

  73. West SG. Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations. Curr Opin Rheumatol. 2018;30(3):243–8.

    Article  CAS  PubMed  Google Scholar 

  74. Judson MA. The clinical features of sarcoidosis: a comprehensive review. Clin Rev Allergy Immunol. 2015;49(1):63–78.

    Article  PubMed  Google Scholar 

  75. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–65.

    Article  CAS  PubMed  Google Scholar 

  76. Sones M, Israel HL. Course and prognosis of sarcoidosis. Am J Med. 1960;29:84–93.

    Article  CAS  PubMed  Google Scholar 

  77. Scadding JG. Sarcoidosis, with special reference to lung changes. Br Med J. 1950;1(4656):745–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2(5261):1165–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. Am J Roentgenol. 2000;174(6):1751–7.

    Article  CAS  Google Scholar 

  80. Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc. 2013;10(4):362–70.

    Article  PubMed  Google Scholar 

  81. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med. 1994;149(4 Pt 1):893–8.

    Article  CAS  PubMed  Google Scholar 

  82. Lopes AJ, de Menezes SL, Dias CM, de Oliveira JF, Mainenti MR, Guimaraes FS. Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis. Lung. 2011;189(5):425–31.

    Article  PubMed  Google Scholar 

  83. Kantartzis SN, Dacic S, Strollo DC. AIRP best cases in radiologic-pathologic correlation: pulmonary sarcoidosis complicated by aspergilloma formation. Radiographics. 2012;32(2):469–73.

    Article  PubMed  Google Scholar 

  84. Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon JJ, Sprunger D, et al. Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest. 2011;140(5):1261–6.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis features in 170 patients. Respir Med. 2003;97(8):978–82.

    Article  PubMed  Google Scholar 

  86. Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Resp Crit Care Med. 2010;31(4):442–51.

    Article  Google Scholar 

  87. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885–9.

    Article  CAS  PubMed  Google Scholar 

  88. Benatar SR. Sarcoidosis in South Africa: a comparative study in Whites, Blacks and Coloureds. S Afr Med J. 1977;52(15):602–6.

    CAS  PubMed  Google Scholar 

  89. Ungprasert P, Wetter DA, Crowson CS, Matteson EL. Epidemiology of cutaneous sarcoidosis, 1976–2013: a population-based study from Olmsted County, Minnesota. J Eur Acad Dermatol Venereol. 2016;30(10):1799–804.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Saygin D, Karunamurthy A, English J, Aggarwal R. Tattoo reaction as a presenting manifestation of systemic sarcoidosis. Rheumatology. 2019;58(5):927.

    Article  PubMed  Google Scholar 

  91. Kalb RE, Epstein W, Grossman ME. Sarcoidosis with subcutaneous nodules. Am J Med. 1988;85(5):731–6.

    Article  CAS  PubMed  Google Scholar 

  92. Culver DA, Ribeiro Neto ML, Moss BP, Willis MA. Neurosarcoidosis. Semin Respir CritCare Med. 2017;38(4):499–513.

    Article  Google Scholar 

  93. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42(9):909–17.

    Article  CAS  PubMed  Google Scholar 

  94. Galetta S, Schatz NJ, Glaser JS. Acute sarcoid optic neuropathy with spontaneous recovery. J Clin Neuroophthalmol. 1989;9(1):27–32.

    CAS  PubMed  Google Scholar 

  95. Mansour AM. Sarcoid optic disc edema and optociliary shunts. J Clin Neuroophthalmol. 1986;6(1):47–52.

    CAS  PubMed  Google Scholar 

  96. Lower EE, Weiss KL. Neurosarcoidosis. Clin Chest Med. 2008;29(3):475–92, ix.

    Article  PubMed  Google Scholar 

  97. Hoitsma E, Marziniak M, Faber CG, Reulen JP, Sommer C, De Baets M, et al. Small fibre neuropathy in sarcoidosis. Lancet. 2002;359(9323):2085–6.

    Article  CAS  PubMed  Google Scholar 

  98. Nery PB, Mc Ardle BA, Redpath CJ, Leung E, Lemery R, Dekemp R, et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2014;37(3):364–74.

    Article  PubMed  Google Scholar 

  99. Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624–32.

    Article  PubMed  Google Scholar 

  100. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43(7–8):372–6.

    CAS  PubMed  Google Scholar 

  101. Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018;51(1):1700991.

    Article  PubMed  Google Scholar 

  102. Chau EM, Fan KY, Chow WH. Cardiac sarcoidosis: a potentially fatal but treatable form of infiltrative heart disease. Hong Kong Med J. 2006;12(1):65–7.

    CAS  PubMed  Google Scholar 

  103. Nery PB, Beanlands RS, Nair GM, Green M, Yang J, McArdle BA, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875–81.

    Article  PubMed  Google Scholar 

  104. Sweiss NJ, Patterson K, Sawaqed R, Jabbar U, Korsten P, Hogarth K, et al. Rheumatologic manifestations of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):463–73.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Visser H, Vos K, Zanelli E, Verduyn W, Schreuder GM, Speyer I, et al. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis. 2002;61(6):499–504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Rizzato G, Colombo P. Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13(2):167–72.

    CAS  PubMed  Google Scholar 

  107. Sharma OP. Renal sarcoidosis and hypercalcemia. Eur Respir Mon. 2005;32:220–32.

    Google Scholar 

  108. Mahévas M, Lescure FX, Boffa JJ, Delastour V, Belenfant X, Chapelon C, et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine. 2009;88(2):98–106.

    Article  PubMed  Google Scholar 

  109. Korenromp IH, Grutters JC, van den Bosch JM, Heijnen CJ. Post-inflammatory fatigue in sarcoidosis: personality profiles, psychological symptoms and stress hormones. J Psychosom Res. 2012;72(2):97–102.

    Article  PubMed  Google Scholar 

  110. Korenromp IHE, Heijnen CJ, Vogels OJM, van den Bosch JMM, Grutters JC. Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest. 2011;140(2):441–7.

    Article  PubMed  Google Scholar 

  111. Strookappe B, De Vries J, Elfferich M, Kuijpers P, Knevel T, Drent M. Predictors of fatigue in sarcoidosis: the value of exercise testing. Respir Med. 2016;116:49–54.

    Article  PubMed  Google Scholar 

  112. De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol. 2004;9(Pt 3):279–91.

    Article  PubMed  Google Scholar 

  113. Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M. Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration. 2010;80(3):212–9.

    Article  CAS  PubMed  Google Scholar 

  114. De Vries J, Lower EE, Drent M. Quality of life in sarcoidosis: assessment and management. Semin Respir Crit Care Med. 2010;31(4):485–93.

    Article  PubMed  Google Scholar 

  115. Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14(1):73–6.

    CAS  PubMed  Google Scholar 

  116. Klatskin G. Hepatic granulomata: problems in interpretation. Mt Sinai J Med. 1977;44(6):798–812.

    CAS  PubMed  Google Scholar 

  117. Rosé CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP, et al. Blau syndrome mutation of CARD15/NOD2in sporadic early onset granulomatous arthritis. J Rheumatol. 2005;32:373–5.

    PubMed  Google Scholar 

  118. Rosé CD, Aróstegui JI, Martin TM, Espada G, Scalzi L, Yagüe J, et al. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009;60:1797–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Wouters CH, et al. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol. 2014;12:33.

    Article  Google Scholar 

  120. Clark SK. Sarcoidosis in children. Pediatr Dermatol. 1987;4(4):291–9.

    Article  CAS  PubMed  Google Scholar 

  121. Cohen KL, Peiffer RL, Powell DA. Sarcoidosis and ocular disease in a young child. A case report and review of the literature. Arch Ophthalmol. 1981;99(3):422–4.

    Article  CAS  PubMed  Google Scholar 

  122. Hetherington S. Sarcoidosis in young children. Am J Dis Child. 1982;136(1):13–5.

    CAS  PubMed  Google Scholar 

  123. Milman N, Hoffmann AL, Byg KE. Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis. Acta Paediatr. 1998;87:871–8.

    Article  CAS  PubMed  Google Scholar 

  124. Lindsley CB, Petty RE. Overview and report on international registry of sarcoid arthritis in childhood. Curr Rheumatol Rep. 2000;2(4):343–8.

    Article  CAS  PubMed  Google Scholar 

  125. Mallory SB, Paller AS, Ginsburg BC, McCrossin ID, Abernathy R. Sarcoidosis in children: differentiation from juvenile rheumatoid arthritis. Pediatr Dermatol. 1987;4(4):313–9.

    Article  CAS  PubMed  Google Scholar 

  126. Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol. 1986 Jan-Feb;30(4):215–28.

    Article  CAS  PubMed  Google Scholar 

  127. Khan JA, Hoover DL, Giangiacomo J, Singsen BH. Orbital and childhood sarcoidosis. J Pediatr Ophthalmol Strabismus. 1986;23(4):190–4.

    Article  CAS  PubMed  Google Scholar 

  128. Rosé CD, Wouters C. Pediatric sarcoidosis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, editors. Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2016. p. 517–25.

    Chapter  Google Scholar 

  129. Evans SS, Fisher RG, Scott MA, Kennedy BG, Brock JW, Wilson GJ. Sarcoidosis presenting as bilateral testicular masses. Pediatrics. 1997;100(3 Pt 1):392–4.

    Article  CAS  PubMed  Google Scholar 

  130. Schaeffer J, Nussbaum M, Meyersfield S. Paratesticular mass as a presenting sign of sarcoidosis. Pediatrics. 1980;66(3):462–3.

    Article  CAS  PubMed  Google Scholar 

  131. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14(4):735–7.

    Article  CAS  PubMed  Google Scholar 

  132. Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, et al. The diagnostic pathway to sarcoidosis. Chest. 2003;123(2):406–12.

    Article  PubMed  Google Scholar 

  133. Valeyre D, Bernaudin JF, Uzunhan Y, Kambouchner M, Brillet PY, Soussan M, et al. Clinical presentation of sarcoidosis and diagnostic work-up. Semin Respir Crit Care Med. 2014;35(3):336–51.

    Article  PubMed  Google Scholar 

  134. Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):83–101.

    Article  PubMed  Google Scholar 

  135. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS research group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(1):75–86.

    CAS  PubMed  Google Scholar 

  136. Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, et al. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(1):19–27.

    PubMed  Google Scholar 

  137. Herbort CP, Rao NA, Mochizuki M, Bodaghi B, Baarsma SG, Chee SP, et al. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–9.

    Article  CAS  PubMed  Google Scholar 

  138. Tournoy KG, Bolly A, Aerts JG, Pierard P, De Pauw R, Leduc D, et al. The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis. Eur Respir J. 2010;35(6):1329–35.

    Article  CAS  PubMed  Google Scholar 

  139. Trisolini R, Lazzari Agli L, Cancellieri A, Poletti V, Candoli P, Paioli D, et al. Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(2):147–51.

    PubMed  Google Scholar 

  140. von Bartheld MB, Dekkers OM, Szlubowski A, Eberhardt R, Herth FJ, in’t Veen JC, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013;309(23):2457–64.

    Article  Google Scholar 

  141. Navani N, Lawrence DR, Kolvekar S, Hayward M, McAsey D, Kocjan G, et al. Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med. 2012;186(3):255–60.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Nessan VJ, Jacoway JR. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N Engl J Med. 1979;301(17):922–4.

    Article  CAS  PubMed  Google Scholar 

  143. Merritt JC, Ross G, Avery A. Conjunctival biopsy in sarcoidosis: 4 year NCMH experience. NC Med J. 1983;44(10):636–7.

    CAS  Google Scholar 

  144. Jirawuthiworavong G, Rubinstein D, Turbin RE. Should conjunctival biopsy be performed for definitive diagnosis of sarcoidosis. J Neuroophthalmol. 2018;38(2):217–22.

    Article  PubMed  Google Scholar 

  145. Chung YM, Lin YC, Huang DF, Hwang DK, Ho DM. Conjunctival biopsy in sarcoidosis. J Chin Med Assoc. 2006;69(10):472–7.

    Article  PubMed  Google Scholar 

  146. Pichler MR, Flanagan EP, Aksamit AJ, Leavitt JA, Salomão DR, Keegan BM. Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology. Neurol Clin Pract. 2015;5(3):216–23.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Tannen BL, Kolomeyer AM, Turbin RE, Frohman L, Langer PD, Oh C, et al. Lacrimal gland uptake of (67) Ga-gallium citrate correlates with biopsy results in patients with suspected sarcoidosis. Ocul Immunol Inflamm. 2014;22(1):15–22.

    Article  CAS  PubMed  Google Scholar 

  148. Mostard RL, van Kroonenburgh MJ, Drent M. The role of the PET scan in the management of sarcoidosis. Curr Opin Pulm Med. 2013;19(5):538–44.

    Article  PubMed  Google Scholar 

  149. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–14.

    Article  PubMed  Google Scholar 

  150. Costabel U. CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir J. 1997;10(12):2699–700.

    Article  CAS  PubMed  Google Scholar 

  151. Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31(4):404–8.

    Article  PubMed  Google Scholar 

  152. Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1997;10(12):2716–21.

    Article  CAS  PubMed  Google Scholar 

  153. Heron M, Slieker WA, Zanen P, van Lochem EG, Hooijkaas H, van den Bosch JM, et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol. 2008;126(3):338–44.

    Article  CAS  PubMed  Google Scholar 

  154. Bretagne L, Diatta ID, Faouzi M, Nobile A, Bongiovanni M, Nicod LP, et al. Diagnostic value of the CD103+CD4+/CD4+ ratio to differentiate sarcoidosis from other causes of lymphocytic alveolitis. Respiration. 2016;91(6):486–96.

    Article  CAS  PubMed  Google Scholar 

  155. Hyldgaard C, Kaae S, Riddervold M, Hoffmann HJ, Hilberg O. Value of s-ACE, BAL lymphocytosis, and CD4+/CD8+ and CD103+CD4+/CD4+ T-cell ratios in diagnosis of sarcoidosis. Eur Respir J. 2012;39(4):1037–9.

    Article  CAS  PubMed  Google Scholar 

  156. Criado E, Sánchez M, Ramírez J, Arguis P, de Caralt TM, Perea RJ, et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics. 2010;30(6):1567–86.

    Article  PubMed  Google Scholar 

  157. Nunes H, Brillet PY, Valeyre D, Brauner MW, Wells AU. Imaging in sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):102–20.

    Article  PubMed  Google Scholar 

  158. Nunes H, Uzunhan Y, Freynet O, Humbert M, Brillet PY, Kambouchner M, et al. Pulmonary hypertension complicating sarcoidosis. Presse Med. 2012;41(6 Pt 2):e303–16.

    Article  PubMed  Google Scholar 

  159. Greco A, Steiner RE. Magnetic resonance imaging in neurosarcoidosis. Magn Reson Imaging. 1987;5(1):15–21.

    Article  CAS  PubMed  Google Scholar 

  160. Adams H, Keijsers RG, Korenromp IH, Grutters JC. FDG PET for gauging of sarcoid disease activity. Semin Respir Crit Care Med. 2014;35(3):352–61.

    Article  PubMed  Google Scholar 

  161. Treglia G, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(2):87–94.

    CAS  PubMed  Google Scholar 

  162. Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008;35(5):933–41.

    Article  PubMed  Google Scholar 

  163. Mostard RL, Vöö S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med. 2011;105(12):1917–24.

    Article  CAS  PubMed  Google Scholar 

  164. Karma A, Poukkula AA, Ruokonen AO. Assessment of activity of ocular sarcoidosis by gallium scanning. Br J Ophthalmol. 1987;71(5):361–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  165. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med. 1990;31(12):1909–14.

    CAS  PubMed  Google Scholar 

  166. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest. 2007;132(1):207–13.

    Article  PubMed  Google Scholar 

  167. Cremers J, Drent M, Driessen A, Nieman F, Wijnen P, Baughman R, et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol. 2012;24(1):17–24.

    Article  PubMed  Google Scholar 

  168. Handa T, Nagai S, Ueda S, Chin K, Ito Y, Watanabe K, et al. Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27(1):27–35.

    CAS  PubMed  Google Scholar 

  169. Baba Y, Kubo T, Kitaoka H, Okawa M, Yamanaka S, Kawada Y, et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J. 2012;53(5):287–92.

    Article  CAS  PubMed  Google Scholar 

  170. Ramos-Casals M, Retamozo S, Sisó-Almirall A, Pérez-Alvarez R, Pallarés L, Brito-Zerón P. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol. 2019;15(4):391–405.

    Article  CAS  PubMed  Google Scholar 

  171. Lieberman J. Enzymes in sarcoidosis. Angiotensin-converting-enzyme (ACE). Clin Lab Med. 1989;9(4):745–55.

    Article  CAS  PubMed  Google Scholar 

  172. Chopra A, Kalkanis A, Judson MA. Biomarkers in sarcoidosis. Expert Rev Clin Immunol. 2016;12(11):1191–208.

    Article  CAS  PubMed  Google Scholar 

  173. Thi Hong Nguyen C, Kambe N, Kishimoto I, Ueda-Hayakawa I, Okamoto H. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement. J Dermatol. 2017;44(7):789–97.

    Article  CAS  PubMed  Google Scholar 

  174. Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study. Lung. 2016;194(1):91–5.

    Article  CAS  PubMed  Google Scholar 

  175. Gundlach E, Hoffmann MM, Prasse A, Heinzelmann S, Ness T. Interleukin-2 receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis. PLoS One. 2016;11(1):e0147258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  176. Baughman RP, Ploysongsang Y, Roberts RD, Srivastava L. Effects of sarcoid and steroids on angiotensin-converting enzyme. Am Rev Respir Dis. 1983;128(4):631–3.

    CAS  PubMed  Google Scholar 

  177. Baltzan M, Mehta S, Kirkham TH, Cosio MG. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med. 1999;160(1):192–7.

    Article  CAS  PubMed  Google Scholar 

  178. Vorselaars AD, Crommelin HA, Deneer VH, Meek B, Claessen AM, Keijsers RG, et al. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. Eur Respir J. 2015;46(1):175–85.

    Article  CAS  PubMed  Google Scholar 

  179. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  180. Ruprecht B, Schürmann M, Ziegenhagen MW, vom Bauer E, Meier D, Schlaak M, et al. Corrected normal values for serum ACE by genotyping the deletion-/insertion-polymorphism of the ACE gene. Pneumologie. 2001;55(7):326–32.

    Article  CAS  PubMed  Google Scholar 

  181. Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Müller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J. 2006;28(6):1085–90.

    Article  CAS  PubMed  Google Scholar 

  182. Stokes GS, Monaghan JC, Schrader AP, Glenn CL, Ryan M, Morris BJ. Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity. Aust NZ J Med. 1999;29(3):315–8.

    Article  CAS  Google Scholar 

  183. Eurelings LEM, Miedema JR, Dalm VASH, van Daele PLA, van Hagen PM, van Laar JAM, et al. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One. 2019;14(10):e0223897.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Ungprasert P, Ryu JH, Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358–75.

    Article  PubMed  PubMed Central  Google Scholar 

  185. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149–73.

    CAS  PubMed  Google Scholar 

  186. Ribeiro Neto ML, Culver DA. Sarcoidosis: treatments beyond prednisone and methotrexate. Expert Rev Respir Med. 2017;11(3):167–70.

    Article  CAS  PubMed  Google Scholar 

  187. Baughman RP, Barney JB, O'Hare L, Lower EE. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respir Med. 2016;110:66–72.

    Article  PubMed  Google Scholar 

  188. Schutt AC, Bullington WM, Judson MA. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med. 2010;104(5):717–23.

    Article  PubMed  Google Scholar 

  189. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(1):60–6.

    CAS  PubMed  Google Scholar 

  190. Cremers JP, Drent M, Bast A, Shigemitsu H, Baughman RP, Valeyre D, et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med. 2013;19(5):545–61.

    Article  CAS  PubMed  Google Scholar 

  191. Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M, et al. Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest. 2013;144(3):805–12.

    Article  CAS  PubMed  Google Scholar 

  192. James WE, Baughman R. Treatment of sarcoidosis: grading the evidence. Expert Rev Clin Pharmacol. 2018;11(7):677–87.

    Article  CAS  PubMed  Google Scholar 

  193. Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31(6):1189–96.

    Article  CAS  PubMed  Google Scholar 

  194. Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(3):201–8.

    PubMed  Google Scholar 

  195. Sweiss NJ, Noth I, Mirsaeidi M, Zhang W, Naureckas ET, Hogarth DK, et al. Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(1):46–54.

    PubMed  Google Scholar 

  196. Crommelin HA, van der Burg LM, Vorselaars AD, Drent M, van Moorsel CH, Rijkers GT, et al. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Respir Med. 2016;115:72–7.

    Article  PubMed  Google Scholar 

  197. Kamphuis LS, Lam-Tse WK, Dik WA, van Daele PL, van Biezen P, Kwekkeboom DJ, et al. Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis. Am J Respir Crit Care Med. 2011;184(10):1214–6.

    Article  PubMed  Google Scholar 

  198. Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, et al. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J. 2014;44(5):1296–307.

    Article  CAS  PubMed  Google Scholar 

  199. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003;124(1):177–85.

    Article  CAS  PubMed  Google Scholar 

  200. Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis. Chest. 2002;122(1):227–32.

    Article  CAS  PubMed  Google Scholar 

  201. Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol. 2004;50(2):235–41.

    Article  PubMed  Google Scholar 

  202. Abril A, Cohen MD. Rheumatologic manifestations of sarcoidosis. Curr Opin Rheumatol. 2004;16(1):51–5.

    Article  PubMed  Google Scholar 

  203. Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin N Am. 2017;43(4):593–606.

    Article  Google Scholar 

  204. Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, et al. Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol. 2017;264(5):891–7.

    Article  CAS  PubMed  Google Scholar 

  205. Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29(9):1034–41.

    Article  PubMed  Google Scholar 

  206. Nagai S, Yokomatsu T, Tanizawa K, Ikezoe K, Handa T, Ito Y, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med. 2014;53(5):427–33.

    Article  CAS  PubMed  Google Scholar 

  207. Krause ML, Cooper LT, Chareonthaitawee P, Amin S. Successful use of rituximab in refractory cardiac sarcoidosis. Rheumatology. 2016;55(1):189–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachussetts Eye Research and Surgery Institution, Waltham, MA, USA

    Charles Stephen Foster & Silvana Belotto

  2. Ocular Immunology and Uveitis Foundation (OIUF), Waltham, MA, USA

    Charles Stephen Foster

  3. Department of Ophthalmology, Harvard Medical School, Boston, MA, USA

    Charles Stephen Foster

  4. Department of Ophthlamology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain

    Andrea Alvarez-Nóvoa

Authors
  1. Charles Stephen Foster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvana Belotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Alvarez-Nóvoa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles Stephen Foster .

Editor information

Editors and Affiliations

  1. Casey Eye Institute, Oregon Health & Science, Portland, OR, USA

    Daniel M. Albert

  2. Department of Ophthalmology, Massachusetts Eye and Ear, Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Joan W. Miller

  3. Department of Ophthalmology, University of Illinois College of Medicine, University of Illinois at Chicago, Chicago, IL, USA

    Dimitri T. Azar

  4. Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA

    Lucy H. Young

Section Editor information

  1. Penn State College of Medicine, Penn State Eye Center, Hershey, Pennsylvania, USA

    Jeffrey M. Sundstrom

  2. Department of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, USA

    David A. Quillen

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Foster, C.S., Belotto, S., Alvarez-Nóvoa, A. (2022). Systemic Manifestations of Sarcoidosis. In: Albert, D.M., Miller, J.W., Azar, D.T., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-42634-7_302

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42634-7_302

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42633-0

  • Online ISBN: 978-3-030-42634-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation